Drug Information

Drug General Information
Drug ID
D06YDW
Former ID
DNC013812
Drug Name
23-hydroxybetulinic acid
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529507]
Structure
Download
2D MOL

3D MOL
Formula
C30H48O4
Canonical SMILES
CC(=C)C1CCC2(C1C3CCC4C5(CCC(C(C5CCC4(C3(CC2)C)C)(C)CO)O<br />)C)C(=O)O
InChI
1S/C30H48O4/c1-18(2)19-9-14-30(25(33)34)16-15-28(5)20(24(19)30)7-8-22-26(3)12-11-23(32)27(4,17-31)21(26)10-13-29(22,28)6/h19-24,31-32H,1,7-17H2,2-6H3,(H,33,34)/t19-,20+,21+,22+,23-,24+,26-,27-,28+,29+,30-/m0/s1
InChIKey
HXWLKAXCQLXHML-WGOZWDAUSA-N
PubChem Compound ID
21672692
Target and Pathway
Target(s) Glycogen phosphorylase, muscle form Target Info Inhibitor [529507]
BioCyc Pathway Glycogenolysis
KEGG Pathway Starch and sucrose metabolism
Metabolic pathways
Insulin signaling pathway
Glucagon signaling pathway
PANTHER Pathway Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway
WikiPathways Glycogen Metabolism
Metabolism of carbohydrates
References
Ref 529507J Med Chem. 2008 Jun 26;51(12):3540-54. Epub 2008 Jun 3.Naturally occurring pentacyclic triterpenes as inhibitors of glycogen phosphorylase: synthesis, structure-activity relationships, and X-ray crystallographic studies.
Ref 529507J Med Chem. 2008 Jun 26;51(12):3540-54. Epub 2008 Jun 3.Naturally occurring pentacyclic triterpenes as inhibitors of glycogen phosphorylase: synthesis, structure-activity relationships, and X-ray crystallographic studies.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.